Heather A. Hirsch, Ph.D. A biomarker-driven approach for the development of the ICOS agonist antibody, JTX-2011. Presented at SITC Annual Meeting, November 8, 2017.
Contact Us
Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge, MA 02139
Phone: (857) 259-3840
Fax: (888) 459-2940
For Investor and Media inquiries, please contact:
Malin Deon
(857) 259-3843 mdeon@jouncetx.com